Eledon Pharmaceuticals, Inc. Fair Value of Assets Acquired
Eledon Pharmaceuticals, Inc. (ELDN) reported Fair Value of Assets Acquired of $3.07 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueOfAssetsAcquired · last filed 2019-03-28
- Eledon Pharmaceuticals, Inc. fair value of assets acquired for the quarter ending 2017-12-31 was $0.00.
- Eledon Pharmaceuticals, Inc. fair value of assets acquired for the quarter ending 2017-09-30 was $0.00.
- Eledon Pharmaceuticals, Inc. fair value of assets acquired for fiscal 2017 was $3.07M.
| Period end | Fair Value of Assets Acquired 3 month | Fair Value of Assets Acquired 6 month | Fair Value of Assets Acquired 9 month | Fair Value of Assets Acquired 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $0.00 derived: sum of 2 quarters · filed 2019-03-28 | $3.07M 10-K · filed 2019-03-28 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $3.07M 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | $3.07M 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |